Research has shown that the balance between Treg and TGF-β levels in the SG of early-stage SS model mice is significantly disrupted compared to normal controls due to the overactivation of Th17 and IL-17 cells (65). The gene discussed is TGFB1; the disease is synovial sarcoma.